GlobeNewswire Inc.··NaInventiva to Showcase MASH Drug Data at EASL Congress 2026
Inventiva will present lanifibranor data at EASL Congress 2026, demonstrating MASH improvements independent of weight loss and linked to adiponectin induction.
IVAclinical triallanifibranor